Organon & Co | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Celltrion KRW 17.14T 298.25B 2025-03
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Gilead Sciences USD 19.67B 596M 2025-06
Glaxosmithkline GBP 13.67B 337M 2024-12
Kangmei Pharma CNY 7.18B 8.52M 2025-03
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 581.54M 98.78M 2024-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.33M 9.6M 2024-12
Merck USD 48.34B 2.02B 2025-03
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Novartis USD 44.05B 729M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Organon & Co USD 542M 70M 2025-03
Pharma Mar EUR 201.53M 4.06M 2025-06
Qiagen NV USD 3.51B 97.61M 2025-06
Sartorius EUR 2.66B 51.3M 2025-06
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Tilray USD 3.47B 5.16M 2024-11


Organon & Co Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.